Washout Period for Pregnancy Post Isotretinoin Therapy - PubMed
- ️Wed Jan 01 2020
Washout Period for Pregnancy Post Isotretinoin Therapy
Hina Jajoria et al. Indian Dermatol Online J. 2020.
Abstract
Introduction and background: Isotretinoin is an oral medication used for the treatment of severe acne unresponsive to other medications. This drug is teratogenic and should be prescribed with appropriate caution in selected group of patients. The washout period for pregnancy post isotrenoin therapy has always been a topic of controversy. Several guidelines have recommended a wash out period of one month if pregnancy is planned in a patient being administered with the drug.
Objective: This article discusses the available evidence for different recommended wash out periods and addresses important clinical questions that arise.
Methods: Pubmed research was carried out to collect relevant data using the keywords isotretinoin, pregnancy, contraception, pharmacokinetics and guidelines.
Conclusion: Our research based on the published data concludes that a wash out period of 35 days post isotretinoin therapy is adequate in routine clinical practice.
Keywords: Contraception; India; isotretinoin; new guidelines; pregnancy.
Copyright: © 2020 Indian Dermatology Online Journal.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Teichert M, Visser LE, Dufour M, Rodenburg E, Straus SM, De Smet PA, Stricker BH. Teichert M, et al. Drug Saf. 2010 Apr 1;33(4):315-26. doi: 10.2165/11319190-000000000-00000. Drug Saf. 2010. PMID: 20297863
-
Ibrahim AAM, Alshatri AA, Alsuwaidan S, Almutairi L, Aljasser N, Mahmoud MA, Alaseeri A, Almonysir A, Alotaibi B, Alrasheed B, Alfawaz M. Ibrahim AAM, et al. Saudi Pharm J. 2021 Jun;29(6):527-532. doi: 10.1016/j.jsps.2021.04.013. Epub 2021 Apr 23. Saudi Pharm J. 2021. PMID: 34194259 Free PMC article.
-
AlGhamdi KM, Khurram H, Asiri YA, Mandil A. AlGhamdi KM, et al. Int J Dermatol. 2011 Sep;50(9):1094-8. doi: 10.1111/j.1365-4632.2011.04875.x. Int J Dermatol. 2011. PMID: 22126870
-
Dessinioti C, Zouboulis CC, Bettoli V, Rigopoulos D. Dessinioti C, et al. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):2229-2240. doi: 10.1111/jdv.16430. Epub 2020 May 14. J Eur Acad Dermatol Venereol. 2020. PMID: 32277497 Review.
-
Isotretinoin; A review on the Utilization Pattern in Pregnancy.
Khiali S, Gharekhani A, Entezari-Maleki T. Khiali S, et al. Adv Pharm Bull. 2018 Aug;8(3):377-382. doi: 10.15171/apb.2018.044. Epub 2018 Aug 29. Adv Pharm Bull. 2018. PMID: 30276133 Free PMC article. Review.
Cited by
-
Teratogenic effect of isotretinoin in both fertile females and males (Review).
Draghici CC, Miulescu RG, Petca RC, Petca A, Dumitrașcu MC, Șandru F. Draghici CC, et al. Exp Ther Med. 2021 May;21(5):534. doi: 10.3892/etm.2021.9966. Epub 2021 Mar 23. Exp Ther Med. 2021. PMID: 33815607 Free PMC article. Review.
References
-
- Fogh K, Voorhees JJ, Astrom A. Expression, purification and binding properties of human cellular retinoic acid-binding protein type I and II. Arch Biochem Biophys. 1993;300:751–5. - PubMed
-
- Levin AA, Bosakowski T, Kazmer S, Grippo JF. 13-cis retinoic acid does not bind toretinoic acid receptors alpha, beta and gamma. Toxicologist. 1992;12:181.
-
- Ott F, Bollag W, Geiger JM. Oral 9-cis-retinoic acid in acne therapy. Dermatology. 1996;193:124–6. - PubMed
LinkOut - more resources
Full Text Sources